Healthcare & Medical Devices Global On demand · 24-48h

Global Endovascular Robot Market Strategic Research Report

Global Endovascular Robot Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Endovascular Robot Market
$1.19B2025
16.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Guidewire Control Robots, Catheter Control Robots, Guidewire–Catheter Integrated Robots, End-Device Control Robots, Others

By Application: Coronary Interventions, Peripheral Vascular Interventions, Neurovascular Interventions, Structural Heart Interventions, Interventional Oncology, Emergency Endovascular Interventions

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Siemens Healthineers, Robocath, Stereotaxis, Johnson And Johnson, Microport Scientific, Beijing Surgerii Technology, Shanghai Robotic Medical Technology, EndoVascular Robotics, Robo Medical, Magellan Robotics, Hansen Medical, Corindus Vascular Robotics, Neurobotics, Auris Health, Remebot, Tinavi Medical Technologies, Ronovo Surgical, Edge Medical Robotics, Xinhua Robotic Medical, WeMed Medical Technology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 137 pages
Market size 2025
$1.19B
Billion USD
Forecast CAGR
16.4%
2025-2032
Forecast 2032
$3.4B
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Endovascular Robot market size is predicted to grow from US$ 1,193 million in 2025 to US$ 3,356 million in 2032; it is expected to grow at a CAGR of 16.4% from 2026 to 2032.

Endovascular Robots are robotic-assisted systems designed to navigate catheters, guidewires, or micro-instruments inside blood vessels to perform minimally invasive procedures such as angioplasty, stent placement, embolization, and thrombectomy. They enhance precision, stability, and operator safety during complex vascular interventions.In 2025, global endovascular robot production reached approximately 1,627 units, with an average global market price of around US$ 750,000 per unit. Annual production capacity is 1,700 units. Gross Profit Margin: 28.2%.The endovascular robot industry chain spans from high-precision component suppliers to hospitals and research institutions. Upstream includes motors, sensors, actuators, and medical-grade electronics essential for precise catheter and guidewire control. Midstream covers robotic system manufacturers, software developers, and system integrators, while downstream consists of hospitals, cath labs, and training centers that implement these robots in cardiovascular, neurovascular, and peripheral interventions.Endovascular robots represent a high-potential but still niche market. While adoption is limited by high system costs and learning curves, their precision, reduced radiation exposure, and procedural consistency offer significant clinical value. Looking forward, integrating AI-assisted navigation and semi-autonomous functions could greatly expand usage and improve outcomes, making these robots a key component in next-generation minimally invasive interventions.

Global key Endovascular Robot players cover Siemens Healthineers, Robocath, Stereotaxis, Johnson And Johnson, Microport Scientific, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Endovascular Robot market?

What factors are driving Endovascular Robot market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Endovascular Robot market opportunities vary by end market size?

How does Endovascular Robot break out by Type, by Application?

This report presents a comprehensive overview of the global Endovascular Robot market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Guidewire Control Robots
  • Catheter Control Robots
  • Guidewire–Catheter Integrated Robots
  • End-Device Control Robots
  • Others

Segment by Level of Automation

  • Manual-Enhanced Endovascular Robots
  • Master–Slave Teleoperated Endovascular Robots
  • Semi-Autonomous Assistive Endovascular Robots
  • Others

Segment by Application

  • Coronary Interventions
  • Peripheral Vascular Interventions
  • Neurovascular Interventions
  • Structural Heart Interventions
  • Interventional Oncology
  • Emergency Endovascular Interventions

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Endovascular Robot market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Coronary Interventions, Peripheral Vascular Interventions, Neurovascular Interventions evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Endovascular Robot Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 16.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.19B
2025
Forecast
$3.4B
2032
CAGR
16.4%
2025–2032
Régions
5
global
Key companies
Siemens HealthineersRobocathStereotaxisJohnson And JohnsonMicroport ScientificBeijing Surgerii TechnologyShanghai Robotic Medical TechnologyEndoVascular Robotics
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Guidewire Control RobotsCatheter Control RobotsGuidewire–Catheter Integrated RobotsEnd-Device Control RobotsOthers
By Application
Coronary InterventionsPeripheral Vascular InterventionsNeurovascular InterventionsStructural Heart InterventionsInterventional OncologyEmergency Endovascular Interventions

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Guidewire Control Robots
  • 3.1.3 Catheter Control Robots
  • 3.1.4 Guidewire–Catheter Integrated Robots
  • 3.1.5 End-Device Control Robots
  • 3.1.6 Others
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Coronary Interventions
  • 4.1.3 Peripheral Vascular Interventions
  • 4.1.4 Neurovascular Interventions
  • 4.1.5 Structural Heart Interventions
  • 4.1.6 Interventional Oncology
  • 4.1.7 Emergency Endovascular Interventions
  • 4.1.8 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Siemens Healthineers
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Robocath
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Stereotaxis
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Johnson And Johnson
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Microport Scientific
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Beijing Surgerii Technology
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Shanghai Robotic Medical Technology
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 EndoVascular Robotics
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Robo Medical
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Magellan Robotics
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Hansen Medical
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Corindus Vascular Robotics
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Neurobotics
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Auris Health
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Remebot
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Tinavi Medical Technologies
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Ronovo Surgical
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Edge Medical Robotics
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Xinhua Robotic Medical
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 WeMed Medical Technology
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Endovascular Robot market?
The global Endovascular Robot market is estimated at US$ 1.19 billion in 2025 (base year) and is projected to reach US$ 3.36 billion by 2032.
How fast is the Endovascular Robot market expected to grow?
The market is expected to grow at a CAGR of 16.4% from 2026 to 2032, expanding from US$ 1.19 billion in 2025 to US$ 3.36 billion in 2032, roughly 2.8 times its base-year value.
What does the Endovascular Robot market cover?
Endovascular Robots are robotic-assisted systems designed to navigate catheters, guidewires, or micro-instruments inside blood vessels to perform minimally invasive procedures such as angioplasty, stent placement, embolization, and thrombectomy. They enhance precision, stability, and operator safety during complex vascular interventions.In 2025, global endovascular robot production reached approximately 1,627 units, with an average global market price of around US$ 750,000 per unit. Annual production capacity is 1,700 units.
What are the main segments of the Endovascular Robot market by type?
By type, the market is segmented into Guidewire Control Robots, Catheter Control Robots, Guidewire–Catheter Integrated Robots, End-Device Control Robots and Others.
Which applications drive demand in the Endovascular Robot market?
Key applications covered include Coronary Interventions, Peripheral Vascular Interventions, Neurovascular Interventions, Structural Heart Interventions, Interventional Oncology and Emergency Endovascular Interventions.
Who are the key players in the Endovascular Robot market?
Key players profiled include Siemens Healthineers, Robocath, Stereotaxis, Johnson And Johnson, Microport Scientific, Beijing Surgerii Technology, Shanghai Robotic Medical Technology and EndoVascular Robotics, among 20 companies covered in total.
Which regions and countries are covered for Endovascular Robot?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Endovascular Robot market?
What factors are driving Endovascular Robot market growth, globally and by region?
Who should buy the Endovascular Robot market report?
The report is intended for manufacturers and solution providers, distributors and end users in Coronary Interventions, Peripheral Vascular Interventions and Neurovascular Interventions, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Endovascular Robot market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.